USP22 is a positive regulator of NFATc2 on promoting IL2 expression

FEBS Lett. 2014 Mar 18;588(6):878-83. doi: 10.1016/j.febslet.2014.02.016. Epub 2014 Feb 20.

Abstract

Nuclear factor of activated T cells (NFAT) is an important regulator of T cell activation. However, the molecular mechanism whereby NFATc2 regulates IL2 transcription is not fully understood. In this study, we showed that ubiquitin-specific protease 22 (USP22), known as a cancer stem cell marker, specifically interacted with and deubiquitinated NFATc2. USP22 stabilized NFATc2 protein levels, which required its deubiquitinase activity. Consistent with these observations, depletion of USP22 in T cells reduced the expression of IL2, which is a cytokine that signifies T effector cell activation. Our findings thus unveil a previously uncharacterized positive regulator of NFATc2, suggesting that targeting the deubiquitinase activity of USP22 could have therapeutic benefit to control IL2 expression and T cell function.

Keywords: Deubiquitinase; IL2; NFATc2; Stability; T cell; USP22.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Knockdown Techniques
  • HEK293 Cells
  • Humans
  • Interleukin-2 / genetics
  • Interleukin-2 / metabolism*
  • Jurkat Cells
  • NFATC Transcription Factors / metabolism*
  • Protein Interaction Mapping
  • Protein Stability
  • RNA, Small Interfering / genetics
  • Thiolester Hydrolases / genetics
  • Thiolester Hydrolases / metabolism*
  • Transcription, Genetic
  • Transcriptional Activation
  • Ubiquitin Thiolesterase
  • Ubiquitination

Substances

  • IL2 protein, human
  • Interleukin-2
  • NFATC Transcription Factors
  • NFATC2 protein, human
  • RNA, Small Interfering
  • Thiolester Hydrolases
  • Ubiquitin Thiolesterase
  • Usp22 protein, human